Regulatory Submission Intelligence and Benefit-Risk Signal Extraction: AI-Driven Frameworks for Optimising Drug Approval Pathway Navigation

Authors

  • Anibal Traça Professor of Informatics, Instituto Superior Técnico (IST)

Keywords:

regulatory submission intelligence, benefit-risk signal extraction, frameworks, optimising drug approval pathway navigation, machine learning

Abstract

Current approaches to drug approval processes have been the subject of criticism and are in need of innovation due to the prevalence of inefficiencies that have resulted in the requirement of years and billions of dollars to bring new treatments to the market. Clinical approval processes involve a cascade of largely sequential examination steps with high significance and expediency, in which the decision at each step ultimately leads to the final approval of the drug.

Downloads

Published

30-06-2026

How to Cite

[1]
“Regulatory Submission Intelligence and Benefit-Risk Signal Extraction: AI-Driven Frameworks for Optimising Drug Approval Pathway Navigation”, IoT and Edge Comp. J, vol. 6, no. 1, pp. 22–30, Jun. 2026, Accessed: Jun. 05, 2026. [Online]. Available: https://thesciencebrigade.com/iotecj/article/view/753